title: Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill.
abstract: OBJECTIVE
  To compare the effectiveness of 70-mg and 200-mg doses of intravenous erythromycin in improving gastric emptying in critically ill patients.
  
  
  METHODS
  Gastric emptying was measured on consecutive days; day 1 (pre-treatment), day 2 (post-treatment) after an intravenous infusion of either 70 or 200 mg erythromycin or saline placebo (0.9%), in a randomized double-blind fashion.
  
  
  METHODS
  Mixed medical/surgical intensive care unit, tertiary referral.
  
  
  METHODS
  Thirty-five randomly selected, mechanically ventilated, enterally fed critically ill patients (median APACHE II score 19 on admission).
  
  
  METHODS
  On day 2 either 70 or 200 mg erythromycin or saline was administered intravenously over 20 min.
  
  
  RESULTS
  Gastric emptying was measured using the [13C]octanoic acid breath test. The gastric emptying coefficient (GEC) and half-emptying time (t1/2) were calculated from the area under the 13CO2-recovery curve. Pre-treatment gastric emptying measurements were similar in all three patient groups. Treatment with both doses of erythromycin significantly reduced the gastric t1/2: 70 mg, 98 min (IQR 88-112); 200 mg, 86 min (75-104); vs. placebo, 122 min (102-190) (p<0.05). The GEC was higher with both doses of erythromycin: 70 mg, 3.8 (3.3-4.0); 200 mg, 4.0 (3.6-4.2); vs. placebo, 2.9 (2.5-3.7) (p<0.05). There was no difference in gastric emptying post-treatment between the two doses of erythromycin. The effect of erythromycin was greatest in patients with delayed gastric emptying.
  
  
  CONCLUSIONS
  Treatment with 70 and 200 mg intravenous erythromycin are equally effective in accelerating gastric emptying in the critically ill.
authors.affiliation: Department of Gastrointestinal Medicine, Royal Adelaide Hospital, 5000, Adelaide, SA, Australia.
authors.forename: Marc A
authors.initials: MA
authors.lastname: Ritz
authors.forename: Marianne J
authors.initials: MJ
authors.lastname: Chapman
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Fraser
authors.forename: Mark E
authors.initials: ME
authors.lastname: Finnis
authors.forename: Ross N
authors.initials: RN
authors.lastname: Butler
authors.forename: Patricia
authors.initials: P
authors.lastname: Cmielewski
authors.forename: Geoffrey P
authors.initials: GP
authors.lastname: Davidson
authors.forename: Deborah
authors.initials: D
authors.lastname: Rea
mesh_terms: D000328:Adult; D000368:Aged; D001944:Breath Tests; D003422:Critical Care; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004750:Enteral Nutrition; D004917:Erythromycin / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005746:Gastric Emptying / Q000187:drug effects*; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007262:Infusions, Intravenous; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged
chemical_list: D005765:Gastrointestinal Agents; D004917:Erythromycin